Gene Therapy Approaches to Replace or Restore Dystrophin PF-06939926 – Kasia Lobello, MD (Pfizer, Inc.) RGX-202 – Jahannaz Dastgir, DO (REGENXBIO) scAAV9.U7-ACCA – Kevin Flanigan, MD (Nationwide Children’s Hospital) SGT-001 – Carl Morris, PhD (Solid Biosciences) SRP-9001 – Teji Singh, MD (Sarepta Therapeutics) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 1:36:00 Addressing the Complexities of Duchenne (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:05:53 Quality of Life and Emotional Health (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 18:59 Our Stories Matter – Lance Hester (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 57:01 Gene Therapy: What We Know Today & Will Need to Know Tomorrow (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings gene therapy 1:44:16 Gene Therapy Trials (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings gene therapy 59:45 Downstream (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 14:33 Our Stories Matter – Stephen Marchesani (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:56:06 Duchenne and the Heart (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings «1…22232425»Page 24 of 25
by: Parent Project Muscular Dystrophy
